A randomized, placebo-controlled trial of IGF-1 for delayed graft function: A human model to study postischemic ARF

Kidney International

Volumn 64, Issue 2, 2003, Pages 593-602

  Hladunewich, Michelle A ^a,b   Corrigan, Geraldine ^a   Derby, Geraldine C ^a   Ramaswamy, Deepa ^a   Kambham, Neeraja ^a   Scandling, John D ^a   Myers, Bryan D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Delayed graft function; IGF 1; Model; Postischemic ARF

Indexed keywords

CREATININE; PLACEBO; RECOMBINANT SOMATOMEDIN C;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTHRALGIA; ARTICLE; BELL PALSY; CADAVER DONOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIALYSIS; FACE EDEMA; FEMALE; FLUSHING; GINGIVA HYPERPLASIA; GLOMERULUS FILTRATION RATE; HEADACHE; HUMAN; INULIN CLEARANCE; JAW DISEASE; KIDNEY ALLOGRAFT; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MYALGIA; OUTCOMES RESEARCH; PERICARDIAL EFFUSION; PERICARDITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 0037781900     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00100.x     Document Type: Article

References (39)

1. HIRSCHBERG R, KOPPLE J, LIPSETT P, et al: Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 55:2423-2432, 1999
2. CLERMONT G, ACKER CG, ANGUS DC, et al: Renal failure in the ICU: Comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int 62:986-996, 2002
3. CHERTOW GM: On the design and analysis of multicenter trials in acute renal failure. Am J Kidney Dis 30(5 Suppl 4):S96-S101, 1997
4. RANGEL-FRAUSTO MS, PITTET D, COSTIGAN M, et al: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:117-123, 1995
5. BRIVET FG, KLEINKNECHT DJ, LOIRAT P, et al: Acute renal failure in intensive care units - Causes, outcome, and prognostic factors of hospital mortality: A prospective, multicenter study. French Study Group on Acute Renal Failure. Crit Care Med 24:192-198, 1996
6. CHEN YC, FANG JT, TIEN YC, et al: Organ system failures predict prognosis in critically ill patients with acute renal failure requiring dialysis. Changgeng Yi Xue Za Zhi 23:8-13, 2000
7. KLEIN HG, DIMITROV D, ATANASOVA I, et al: Atrial natriuretic factor infusion following acute renal ischemia in anesthetized dogs. Ren Physiol Biochem 15:73-82, 1992
8. KELLY KJ, WILLIAMS WW, JR, COLVIN RB, et al: Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA 91:812-816, 1994
9. DING H, KOPPLE JD, COHEN A, et al: Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J Clin Invest 91:2281-2287, 1993
10. MILLER SB, MARTIN DR, KISSANE J, et al: Insulin-like growth factor I accelerates recovery from ischemic acute tubular necrosis in the rat. Proc Natl Acad Sci USA 89:11876-11880, 1992
11. CHIAO H, KOHDA Y, MCLEROY P, et al: Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 99:1165-1172, 1997
12. NOIRI E, GAILIT J, SHETH D, et al: Cyclic RGD peptides ameliorate ischemic acute renal failure in rats. Kidney Int 46:1050-1058, 1994
13. CONGER JD, FALK SA, HAMMOND WS: Atrial natriuretic peptide and dopamine in established acute renal failure in the rat. Kidney Int 40:21-28, 1991
14. ALLGREN RL, MARBURY TC, RAHMAN SN, et al: Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 336:828-834, 1997
15. LEWIS J, SALEM MM, CHERTOW GM, et al: Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis 36:767-774, 2000
16. MILLER SB, MARTIN DR, KISSANE J, et al: Rat models for clinical use of insulin-like growth factor I in acute renal failure. Am J Physiol 266:F949-F956, 1994
17. ALEJANDRO V, SCANDLING JD, JR, SIBLEY RK, et al: Mechanisms of filtration failure during postischemic injury of the human kidney. A study of the reperfused renal allograft. J Clin Invest 95:820-831, 1995
18. RAMASWAMY D, CORRIGAN G, POLHEMUS C, et al: Maintenance and recovery stages of postischemic acute renal failure in humans. Am J Physiol 282:F271-F280, 2002
19. MYERS BD, CHUI F, HILBERMAN M, et al: Transtubular leakage of glomerular filtrate in human acute renal failure. Am J Physiol 237:F319-F325, 1979
20. KWON O, NELSON WJ, SIBLEY R, et al: Backleak, tight junctions, and cell-cell adhesion in postischemic injury to the renal allograft. J Clin Invest 101:2054-2064, 1998
21. KWON O, CORRIGAN G, MYERS BD, et al: Sodium reabsorption and distribution of Na+/K+-ATPase during postischemic injury to the renal allograft. Kidney Int 55:963-975, 1999
22. ALEJANDRO VS, NELSON WJ, HUIE P, et al: Postischemic injury, delayed function and Na+/K(+)-ATPase distribution in the transplanted kidney. Kidney Int 48:1308-1315, 1995
23. O'SHEA MH, MILLER SB, HAMMERMAN MR: Effects of IGF-I on renal function in patients with chronic renal failure. Am J Physiol 264:F917-F922, 1993
24. CLARK R, MORTENSEN D, RABKIN R: Recovery from acute ischaemic renal failure is accelerated by des-(1-3)-insulin-like growth factor-1. Clin Sci 86:709-714, 1994
25. NOGUCHI S, KASHIHARA Y, IKEGAMI Y, et al: Insulin-like growth factor-I ameliorates transient ischemia-induced acute renal failure in rats. J Pharmacol Exp Ther 267:919-926, 1993
26. MILLER SB, MOULTON M, O'SHEA M, et al: Effects of IGF-I on renal function in end-stage chronic renal failure. Kidney Int 46:201-207, 1994
27. FJELDBO W, STAMEY TA: Adapted method for determination of inulin in serum and urine with an autoanalyzer. J Lab Clin Med 72:353-358, 1968
28. DAUGHADAY WH, ROTWEIN P: Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Review 206 refs. Endocr Rev 10:68-91, 1989
29. POWELL DR, ROSENFELD RG, BAKER BK, et al: Serum somatomedin levels in adults with chronic renal failure: The importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum. J Clin Endocrinol Metab 63:1186-1192, 1986
30. BLAND JM, ALTMAN DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 8:307-310, 1986
31. HIRSCHBERG R, DING H: Mechanisms of insulin-like growth factor-I-induced accelerated recovery in experimental ischemic acute renal failure. Miner Electrolyte Metab 24:211-219, 1998
32. MYERS BD, SOMMER FG, LI K, et al: Determination of blood flow to the transplanted kidney. A novel application of phase-contrast, cine magnetic resonance imaging. Transplantation 57:1445-1450, 1994
33. MAESTRI M, DAFOE DC, ADAMS GA, et al: Insulin-like growth factor-I ameliorates delayed kidney graft function and the acute nephrotoxic effects of cyclosporine. Transplantation 64:185-190, 1997
34. HIRSCHBERG R, KOPPLE JD: Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats. J Clin Invest 83:326-330, 1989
35. HIRSCHBERG R, BRUNORI G, KOPPLE JD, et al: Effects of insulin-like growth factor I on renal function in normal men. Kidney Int 43:387-397, 1993
36. ANDERSSON G, JENNISCHE E: IGF-I immunoreactivity is expressed by regenerating renal tubular cells after ischaemic injury in the rat. Acta Physiol Scand 132:453-457, 1988
37. BLAZER-YOST BL, WATANABE M, HAVERTY TP, et al: Role of insulin and IGF1 receptors in proliferation of cultured renal proximal tubule cells. Biochim Biophys Acta 1133:329-335, 1992
38. STAR RA: Treatment of acute renal failure. Kidney Int 54:1817-1831, 1998
39. MORAN SM, MYERS BD: Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int 27:928-937, 1985